Castellsagu X, Muoz N, De Stefani E, Victora CG, Castelletto R, Roln PA
In conclusion, both Wegovy and Mounjaro offer promising options for individuals struggling with obesity or overweight conditions
The new framework represents an important shift in how innovative therapies are assessed, strengthening collaboration between EU Member States through Joint Clinical Assessments while placing greater emphasis on outcomes that matter to patients and healthcare systems
GLP-1s have been shown to reduce inflammatory markers, such as C-reactive protein (CRP), and decrease the production of pro-inflammatory cytokines
For those with existing heart risk factors, GLP-1 injections could offer significant protection